Full Press Release Details
dupixent dupilumab to treat chronic spontaneous urticaria csu advances in eu with positive chmp opinion.
REGN
dupixent dupilumab to treat chronic spontaneous urticaria csu advances in eu with positive chmp opinion
Key Takeaway: dupixent dupilumab to treat chronic spontaneous urticaria csu advances in eu with positive chmp opinion